Funding profile · Post-acute care revenue cycle software

Claim Health

A Y Combinator company that announced a $4.4 million seed round in January 2026. Here is what the announcement says, and what has not shown up in an SEC filing yet.

$4.4MSeed round, company-reported (Jan 2026)
0Form D filings found under Claim Health in SEC EDGAR
4Institutional backers named: Maverick Ventures, Peak XV, Y Combinator, DHVP
30xRevenue growth since the YC batch, company-reported

Data as of September 25, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
Spring 2025 Y Combinator, accelerator investment Not disclosed Y Combinator Accelerator record
Jan 21, 2026 Seed $4.4M announced Led by Maverick Ventures; Peak XV, Y Combinator and DHVP also named, plus unnamed C-suite executives at post-acute care providers Company release

What the filings show

Nothing yet. A search of SEC EDGAR for companies named “claim health” or “claimhealth” returns no Form D filings as of September 2026, eight months after the seed round was announced. Companies sometimes file under a different legal entity name than their public brand, and some private placements are exempt from Form D reporting entirely, so an absence of a filing does not prove the round did not close. It does mean that everything about the round beyond the press release, the amount, the lead investor, the participant list, currently has no filing behind it to check.

Reading the round

  1. No Form D on record.Eight months after the announcement, no Form D naming Claim Health or ClaimHealth turns up in an EDGAR company search. That leaves the $4.4M figure, the investor list, and any earlier YC or angel money resting entirely on the company’s own account and the press it generated.
  2. Four names, no breakdown.Maverick Ventures, Peak XV, Y Combinator and DHVP are all named as participants, but the release does not say how the $4.4M splits among them, or how much came from the unnamed post-acute care executives described as also writing checks.
  3. Y Combinator appears twice.YC is named both as the accelerator that admitted Claim Health in its Spring 2025 batch and as a participant in the seed round, a pattern consistent with an accelerator’s follow-on fund investing again in a company it already backed.
  4. The growth number is unaudited.The reported 30 times revenue growth in under a year is repeated across three business outlets, Business Wire, HIT Consultant and Pulse 2.0, but each traces back to the company as the source, and none reports an underlying revenue figure to check the multiple against.

Commercial signals

Signal Detail Source type
Customers Ascend Health, Interim HealthCare and Home Care RN named as early customers. No independent confirmation of the relationships found. Company-stated
Reported outcomes Over 50% reduction in administrative workload, up to 4 times referral throughput, 30% to 50% fewer preventable denials, all company-reported. Company-stated
Integrations Company describes connecting to EMRs, clearinghouses and payer portals without naming specific systems such as PointClickCare or MatrixCare. Not named
Market framing Company cites about 68,000 post-acute care providers in the US and roughly 13% projected growth in home health volume over five years. Company-stated

What to watch

  • A Form D or other SEC filing tied to the $4.4 million round.
  • A published breakdown of how the round split among Maverick Ventures, Peak XV, Y Combinator and DHVP.
  • Named EHR or clearinghouse integrations rather than a general description.
  • Independent confirmation that Ascend Health, Interim HealthCare and Home Care RN are paying customers.

The Claim Health story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • Ember: Shared investor: M Seed Fund. An AI platform that codes claims, chases prior authorization and writes appeals before a healthcare bill ever goes out the door
  • Invert: Shared investor: M Seed Fund. Software that pulls data off bioreactors and analytical instruments, harmonizes it, and since October 2025 answers questions about it in plain language
  • Science Exchange: Shared investor: Maverick Ventures. A marketplace for ordering experiments that became procurement software for big pharma, and that sourced the laboratories for the largest public test of whether
  • Mecha Health: Shared investor: M Seed Fund. Four University College London researchers built a chest x-ray model that writes the whole report, published benchmarks saying it matches or beats radiologists, and

Sources

  1. CompanyClaim Health Launches AI-Powered Revenue Infrastructure for Post-Acute Care with $4.4M Seed FundingBusiness Wire · Jan 21, 2026
  2. CompanyClaim Health Launches AI-Powered Revenue Infrastructure for Post-Acute Care with $4.4M Seed FundingYahoo Finance, syndicated Business Wire · Jan 21, 2026
  3. IndependentThe Self-Driving Revenue Cycle: Claim Health Raises $4.4M to Fix Post-Acute Care’s Biggest BottleneckHIT Consultant, Fred Pennic · Jan 23, 2026
  4. IndependentClaim Health: $4.4 Million Seed Funding Raised to Automate Post-Acute Revenue Operations with AIPulse 2.0, Amit Chowdhry · Jan 22, 2026
  5. CompanyClaim Health company page and launch postY Combinator
  6. InterviewTransforming Post-Acute Care Operations with the Power of AI: Inside Kevin Calcado’s Journey to Build Claim HealthEvery · 2026
  7. Public recordSEC EDGAR company search, “claim health”, Form DSEC · accessed Sep 2026
  8. Public recordSEC EDGAR company search, “claimhealth”, Form DSEC · accessed Sep 2026

Compiled from SEC and other public records and published reports as of September 25, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date. Healthcare Venture Capital Fund holds no position in Claim Health. This page is not an offer to sell or a recommendation to buy any security.